PROTAC EED degrader-2 is primarily used in biomedical research to target and degrade the EED protein, a core component of the Polycomb Repressive Complex 2 (PRC2). By inducing the degradation of EED, it helps in studying the role of PRC2 in gene silencing and epigenetic regulation. This chemical is particularly valuable in cancer research, as PRC2 is often implicated in tumorigenesis. It provides insights into potential therapeutic strategies for cancers where PRC2 activity is dysregulated. Additionally, it serves as a tool to explore the broader implications of epigenetic modifications in various diseases.